Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant Immunochemotherapy for Locally Advanced Cervical Cancer
NCT07003620Phase 2Recruiting
- Sponsor
- Sun Yat-sen Memorial Hospital
- Start
- Jun 2025
- Primary completion
- Oct 2028
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial in Cervical Cancer (CC), sponsored by Sun Yat-sen Memorial Hospital. Primary endpoint: Objective Response Rate. Started Jun 2025; status: recruiting.
02
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on NCT07003620.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07003620.